spironolactone has been researched along with enmein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, LS; Huang, SX; Sun, HD; Xu, HX; Yang, BL; Yang, J; Zhou, Y | 1 |
| Cai, H; Jiang, J; Li, D; Wang, L; Xu, J; Xu, S; Yao, H; Zhang, Y | 1 |
| He, C; Jia, Y; Ni, X; Wu, X; Xu, J; Xu, S; Yao, H; Zhou, K | 1 |
3 other study(ies) available for spironolactone and enmein
| Article | Year |
|---|---|
Electrospray ionization tandem mass spectrometric analysis of ent-6,7-seco-kaurane diterpenoids from the Isodon species.
Topics: Diterpenes; Diterpenes, Kaurane; Isodon; Spectrometry, Mass, Electrospray Ionization; Spironolactone; Tandem Mass Spectrometry | 2009 |
The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Diterpenes; Diterpenes, Kaurane; Female; Humans; K562 Cells; Mice; Spironolactone; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2012 |
Spirolactone-type and enmein-type derivatives as potential anti-cancer agents derived from oridonin.
Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Diterpenes; Diterpenes, Kaurane; Esters; Humans; Reactive Oxygen Species; Spironolactone; Structure-Activity Relationship | 2022 |